Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Radiolabeled Compounds for Diagnosis and Treatment of Cancer
| Radiolabeled Compounds for Diagnosis and Treatment of Cancer |
| Autore | Kumar Krishan |
| Pubbl/distr/stampa | Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 |
| Descrizione fisica | 1 electronic resource (262 p.) |
| Soggetto topico |
Research & information: general
Chemistry |
| Soggetto non controllato |
positron emission tomography (PET)
pyrazoles fluorine-18 radionuclides PET probes imaging pharmaceuticals hypopharyngeal cancer 188Re-liposome repeated therapy NGS microRNA aprepitant radiopharmaceuticals neurokinin 1 receptor antagonist radionuclide chelators kidney uptake cleavable linkers neutral endopeptidase (NEP) renal brush border enzymes prostate-specific membrane antigen (PSMA) cancer imaging and therapy somatostatin analogs radiolabeling radionuclide therapy imaging adrenergic receptor positron emission tomography radiotracer cholecystokinin-2 receptor minigastrin molecular imaging targeted radiotherapy lutetium-177 EpCAM radionuclide SPECT iodine PIB breast cancer PET target-specific biomolecules immunoPET imaging pharmaceuticals production processes 124I-labeled monoclonal antibodies radiotracers AAZTA scandium-44 FAP SA DPP PREP radioiodine labeling radioiodination biomolecules peptides proteins monoclonal antibodies 123,124,125,131I-labeled molecules and biomolecules |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910557512703321 |
Kumar Krishan
|
||
| Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Targets, Tracers and Translation - Novel Radiopharmaceuticals Boost Nuclear Medicine
| Targets, Tracers and Translation - Novel Radiopharmaceuticals Boost Nuclear Medicine |
| Autore | Reischl Gerald |
| Pubbl/distr/stampa | MDPI - Multidisciplinary Digital Publishing Institute, 2019 |
| Descrizione fisica | 1 electronic resource (214 p.) |
| Soggetto non controllato |
pretargeting
radioiodination neurodegeneration phosphoramidon GRPR molecular imaging allosteric modulator radiosynthesis separation ?-CIT PET/CT imaging technetium-99m gastrin-releasing peptide receptor metabotropic glutamate receptor subtype 5 glutamate oncogenic fusions Fusarinine C hypoxia tirapazamine (TPZ) 68Ga sentinel lymph node 99mTc-radioligand iodine-131 electrophilic radioiodination 4-dioxide (BTDO) minigastrin ceftriaxone tropomyosin receptor kinase carbonic anhydrase IX ABP688 NPY(Y1)R MMPEP radiosensitizer neprilysin-inhibition radiochemistry girentuximab benzotriazine-1 gallium-68 cholecystokinin-2 receptor tumor targeting radioimmunotherapy salivary gland uptake metabolic stability tumor hypoxia multimerization oxidizing agent neuroinflammation gastrin-releasing peptide dextran carbon-11 peptide heterodimers apparent molar activity radiometals microglia rituximab [18F]FMISO [11C]meta-hydroxyephedrine Iodo-Gen® mannose 177Lu-radiopharmaceuticals azomycin nucleosides breast cancer click chemistry small animal imaging SR 4317 benzotriazine-1-monoxide (BTMO) bombesin prostate cancer Chloramine T 99mTc-radiopharmaceuticals ketamine PSMA-617 positron emission tomography hydrazinonicotinic acid (HYNIC) renal cell carcinomas [18F]PSS232 PET endoradiotherapy |
| ISBN | 3-03921-314-8 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910367759003321 |
|
Reischl Gerald
|
||
| MDPI - Multidisciplinary Digital Publishing Institute, 2019 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||